Ulobetasol
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601060 |
ATC code | D07AC21 (WHO) |
Identifiers | |
| |
Synonyms | (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
CAS Number | 98651-66-2 |
PubChem (CID) | 5311167 |
ChemSpider | 4470691 |
UNII | 9P6159HM7T |
KEGG | D08660 |
ChEMBL | CHEMBL1201360 |
Chemical and physical data | |
Formula | C22H27ClF2O4 |
Molar mass | 428.897 |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream.
External links
- halobetasol at the US National Library of Medicine Medical Subject Headings (MeSH)
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.